Wednesday, December 09, 2020

India is major client for COVID-19 Vaccines

India needs 1.6 billion doses to cover 800 million people and achieve 'herd immunity' according to this article.

India has purchased so far,

  • 500 million doses of AstraZeneca vaccine
  • 1 billion of US's NOVAVAX
  • 100 million doses of Sputnik V from Russia's Gamaleya Laboratory

This above is as of November 30 according to data gathered by Duke University Global Health Innovation Center.

According to Aljazeera news there are three priority groups in India:

10 million healthcare workers

20 million front-line workers (police, military, Firefighters etc.)

270 million other vulnerable people (Age>50, etc.)



No comments:

DMCA.com Protection Status